Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Leonid Timashev Reiterated (AXSM) at Buy and Held Target at $131 on, Jul 22nd, 2024
Leonid Timashev of RBC Capital, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $131 on, Jul 22nd, 2024.
Leonid has made no other calls on AXSM in the last 4 months.
There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 1 agrees with Leonid's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jason Gerberry of "B of A Securities" Maintained at Hold with Decreased Target to $95 on, Thursday, July 18th, 2024
These are the ratings of the 7 analyists that currently disagree with Leonid
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $190 on, Thursday, June 6th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
- Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $115 on, Monday, April 29th, 2024
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Wednesday, April 10th, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
